Clinical efficacy and safety outcomes of anlotinib therapy in sarcoma: a systematic review and meta-analysis
{{output}}
Purpose: Sarcomas are rare, aggressive and unpredictable tumors that arise from mesenchymal tissues. Despite treatment, outcomes for advanced or metastatic cases remain poor. Anlotinib is a new oral tyrosine kinase inhibitor that... ...
